Synchronous early-stage endometrial and ovarian cancer

Mauro Signorelli, Robert Fruscio, Andrea Alberto Lissoni, Lissoni AA, Pirovano C, Cecilia Pirovano, Patrizia Perego, Mangioni C, Costantino Mangioni
International Journal of Gynecology & Obstetrics · 2008 · vol. 102(1) , pp. 34–38 · doi:10.1016/j.ijgo.2007.12.012 · PMID:18342863 · W2101778512
Observational OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This retrospective study of 93 women found that early-stage synchronous endometrial and ovarian cancers are not rare, often present with favorable pathologic features, and demonstrate excellent survival rates.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To explore the clinicopathologic findings and oncological outcome of early-stage synchronous endometrial and ovarian malignancies. METHODS: A retrospective study of 93 women with synchronous stage I ovarian and stage I-II endometrial cancer treated between December 1981 and August 2005 in the gynecologic oncology department of San Gerardo Hospital, Italy. RESULTS: Fifty-one percent of the ovarian tumors were stage Ia and 71% of the endometrial cancers had minimal myometrial invasion. Endometrioid histology and grade 2 disease were prevalent in both sites. Hyperplasia and endometriosis coexisted in 71% and 22% of endometrial and ovarian cancers, respectively. The actuarial 5-year disease-free and overall survival rates were 83% and 96%, respectively. CONCLUSION: The incidence of synchronous endometrial and ovarian cancer is not negligible, especially among young women. Synchronous cancers show very favorable pathologic features and have an excellent oncologic outcome. Adjuvant therapy should be tailored according to surgical staging and histology.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometrial Neoplasms Neoplasms, Multiple Primary Ovarian Neoplasms Adult Adult Comorbidity Comorbidity Disease-Free Survival Disease-Free Survival Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Female Female Humans Humans Neoplasm Invasiveness Neoplasm Invasiveness Neoplasms, Multiple Primary Neoplasms, Multiple Primary

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (22)

Cited by (5)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:05:10.907216+00:00
License: CC0 · commercial use OK